Insider filing · GILD
Jeffrey Bluestone
Director
profile →
Gilead Sciences, Inc.
GILD · Healthcare · 88 filings in 24 months
ticker →
Jeffrey Bluestone sold $549K of Gilead Sciences (GILD)
Executed Jul 14 2025, disclosed Jul 15 2025, 1 day later.
Value, as filed
$549K
5,000 sh × $109.74
Executed
Jul 14 2025
the trade date, as filed
Disclosed
Jul 15 2025
1 day after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
JBJeffrey Bluestone (Director) filed 3 Form 4 reports in the trailing twelve months (0 purchases, 3 sales), most often in Gilead Sciences, Inc. (GILD). The largest single filing was $672K of GILD (4,639 sh across 3 lots, as filed), executed Aug 20.
The name
GILDHealthcare · Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Jeffrey Bluestone in GILD
GILDSALE
Gilead Sciences, Inc.
$672K4,639 sh across 3 lots
Exec Aug 20
Filed Aug 21 · 7:22 PM ET GILDSALE Gilead Sciences, Inc. $618K
5,000 sh × $123.50
Exec Jan 20
Filed Jan 21 · 5:30 PM ET GILDSALE Gilead Sciences, Inc. $625K
5,000 sh × $125.08
Exec Nov 28 2025
Filed Dec 1 2025 · 5:30 PM ET GILDSALE Gilead Sciences, Inc. $620K
6,788 sh × $91.39
Exec Nov 26 2024
Filed Nov 27 2024 · 5:30 PM ET